Literature DB >> 28823756

Performance of Low-Dose Perfusion Scintigraphy and CT Pulmonary Angiography for Pulmonary Embolism in Pregnancy.

Jean-Ju Sheen1, Linda B Haramati2, Anna Natenzon1, Hong Ma3, Pamela Tropper1, Anna S Bader3, Leonard M Freeman3, Peter S Bernstein1, Renee M Moadel4.   

Abstract

BACKGROUND: The symptoms of normal pregnancy overlap those of pulmonary embolism (PE). Limited literature suggests that low-dose perfusion scanning (LDQ), which yields lower maternal-fetal radiation exposure than CT pulmonary angiography (CTPA), performs well in excluding PE in pregnant patients.
METHODS: We performed a retrospective cohort study of sequential pregnant women who underwent imaging for PE with LDQ or CTPA between 2008 and 2013 at Montefiore Medical Center. Our practice recommends LDQ for patients with negative results on chest radiographs. Patients were categorized according to initial imaging modality, and a subgroup analysis was performed in patients with asthma. The primary outcome was the negative predictive value (NPV) of imaging determined by VTE diagnosis within 90 days.
RESULTS: Of 322 pregnant women (mean age, 27.3 ± 6.3 years), initial imaging was positive for PE in 2.7% (6 of 225) of LDQs and 4.1% (4 of 97) of CTPAs, negative in 88.0% (198 of 225) of LDQs and 86.6% (84 of 97) of CTPAs, and indeterminate/nondiagnostic in 9.3% (21 of 225) of LDQs and 9.3% (9 of 97) of CTPAs (P = .79). Ten patients (3.1%) were treated for PE. The NPV was 100% for LDQ and 97.5% for CTPA. Subgroup analysis of patients with asthma (23.9% of this population) revealed a high likelihood of a negative study in the LDQ and CTPA groups (74.1% and 87.0%, respectively) and 100% NPV for both modalities.
CONCLUSIONS: PE is an uncommon diagnosis in pregnancy. LDQ and CTPA perform well, with less maternal-fetal radiation exposure with LDQ. Therefore, when available, LDQ is a reasonable first-choice modality for suspected PE in pregnant women with a negative result on chest radiograph.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT pulmonary angiography; asthma; low-dose perfusion scintigraphy; maternal–fetal radiation exposure; pregnancy; pulmonary embolism

Mesh:

Year:  2017        PMID: 28823756     DOI: 10.1016/j.chest.2017.08.005

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Evaluation of CTPA interpreted as limited in pregnant patients suspected for pulmonary embolism.

Authors:  S L Cohen; J Wang; M Mankerian; C Feizullayeva; J A McCandlish; D Barnaby; P Sanelli; T McGinn
Journal:  Emerg Radiol       Date:  2019-12-07

2.  Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis.

Authors:  Cécile Tromeur; Liselotte M van der Pol; Pierre-Yves Le Roux; Yvonne Ende-Verhaar; Pierre-Yves Salaun; Christophe Leroyer; Francis Couturaud; Lucia J M Kroft; Menno V Huisman; Frederikus A Klok
Journal:  Haematologica       Date:  2018-08-16       Impact factor: 9.941

3.  Pulmonary embolism during pregnancy: a 17-year single-center retrospective MDCT pulmonary angiography study.

Authors:  David C Rotzinger; Vincent Dunet; Vesna Ilic; Olivier W Hugli; Reto A Meuli; Sabine Schmidt
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

Review 4.  Pulmonary Embolism and Pregnancy-Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients.

Authors:  Lukas Hobohm; Ioannis T Farmakis; Thomas Münzel; Stavros Konstantinides; Karsten Keller
Journal:  Front Cardiovasc Med       Date:  2022-03-08

5.  To everything there is a season: taxonomy of approaches to the performance of lung scintigraphy in the era of COVID-19.

Authors:  Lionel S Zuckier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03       Impact factor: 9.236

6.  Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge.

Authors:  Arun Kumar; Renée M Moadel; Linda B Haramati; Kenny Ye; Leonard M Freeman; Lionel S Zuckier
Journal:  J Nucl Med       Date:  2021-08-05       Impact factor: 10.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.